中国骨质疏松杂志
中國骨質疏鬆雜誌
중국골질소송잡지
CHINESE JOURNAL OF OSTEOPOROSIS
2014年
10期
1159-1162,1211
,共5页
邓亦峰%陈艳%许碧莲%刘钰瑜%廖进民
鄧亦峰%陳豔%許碧蓮%劉鈺瑜%廖進民
산역봉%진염%허벽련%류옥유%료진민
大黄蒽醌%骨靶向-抗骨质疏松%荧光示踪%大鼠
大黃蒽醌%骨靶嚮-抗骨質疏鬆%熒光示蹤%大鼠
대황은곤%골파향-항골질소송%형광시종%대서
Free rhubarb anthraquinone%Bone targeted anti-osteoporosis%Fluorescent trace%Rat
目的:探讨游离大黄蒽醌类化合物对糖皮质激素诱导性骨质疏松大鼠的骨靶向抗骨质疏松作用。方法采用荧光示踪法观察游离大黄蒽醌类化合物在糖皮质激素诱导的大鼠骨质疏松模型股骨远端骨骺部位对称剖面的荧光,并将其与同位的骨密度( BMD)和骨矿量( BMC)进行关联分析,4月龄雌性SD大鼠126只随机分成泼尼松组( Pred)、泼尼松加大黄蒽醌组( Pred+FAQ)和正常对照组( CON),每个组设7个时间点,灌服给药时间最长13 w。以pQCT骨密度仪分别测定各组各时间点大鼠股骨远心端(2 mm)的骨密度和骨矿量,再以荧光显微镜采集Pred+FAQ组各时间点骨标本骨骺部位对称剖面的荧光图像。结果 Pred+FAQ组股骨远心端的骨密度相对Pred组均显著增加( P<0.05),但Pred+FAQ组各时间点骨标本骨骺部位对称剖面的荧光强度随骨骺“生长-闭合”周期而“上升-消除”,与骨标本的骨密度无显著相关,骨矿量( BMC)也与骨标本的骨密度无显著相关。结论游离大黄蒽醌可以预防糖皮质激素性骨质疏松,具有荧光的游离大黄蒽醌类原型化合物在大鼠股骨中无显著的蓄积现象和骨靶向作用。实验为从骨组织原位药效动力学与药代动力学相关联( pD-pK link)角度探索骨靶向抗骨质疏松成分作了有益的尝试。
目的:探討遊離大黃蒽醌類化閤物對糖皮質激素誘導性骨質疏鬆大鼠的骨靶嚮抗骨質疏鬆作用。方法採用熒光示蹤法觀察遊離大黃蒽醌類化閤物在糖皮質激素誘導的大鼠骨質疏鬆模型股骨遠耑骨骺部位對稱剖麵的熒光,併將其與同位的骨密度( BMD)和骨礦量( BMC)進行關聯分析,4月齡雌性SD大鼠126隻隨機分成潑尼鬆組( Pred)、潑尼鬆加大黃蒽醌組( Pred+FAQ)和正常對照組( CON),每箇組設7箇時間點,灌服給藥時間最長13 w。以pQCT骨密度儀分彆測定各組各時間點大鼠股骨遠心耑(2 mm)的骨密度和骨礦量,再以熒光顯微鏡採集Pred+FAQ組各時間點骨標本骨骺部位對稱剖麵的熒光圖像。結果 Pred+FAQ組股骨遠心耑的骨密度相對Pred組均顯著增加( P<0.05),但Pred+FAQ組各時間點骨標本骨骺部位對稱剖麵的熒光彊度隨骨骺“生長-閉閤”週期而“上升-消除”,與骨標本的骨密度無顯著相關,骨礦量( BMC)也與骨標本的骨密度無顯著相關。結論遊離大黃蒽醌可以預防糖皮質激素性骨質疏鬆,具有熒光的遊離大黃蒽醌類原型化閤物在大鼠股骨中無顯著的蓄積現象和骨靶嚮作用。實驗為從骨組織原位藥效動力學與藥代動力學相關聯( pD-pK link)角度探索骨靶嚮抗骨質疏鬆成分作瞭有益的嘗試。
목적:탐토유리대황은곤류화합물대당피질격소유도성골질소송대서적골파향항골질소송작용。방법채용형광시종법관찰유리대황은곤류화합물재당피질격소유도적대서골질소송모형고골원단골후부위대칭부면적형광,병장기여동위적골밀도( BMD)화골광량( BMC)진행관련분석,4월령자성SD대서126지수궤분성발니송조( Pred)、발니송가대황은곤조( Pred+FAQ)화정상대조조( CON),매개조설7개시간점,관복급약시간최장13 w。이pQCT골밀도의분별측정각조각시간점대서고골원심단(2 mm)적골밀도화골광량,재이형광현미경채집Pred+FAQ조각시간점골표본골후부위대칭부면적형광도상。결과 Pred+FAQ조고골원심단적골밀도상대Pred조균현저증가( P<0.05),단Pred+FAQ조각시간점골표본골후부위대칭부면적형광강도수골후“생장-폐합”주기이“상승-소제”,여골표본적골밀도무현저상관,골광량( BMC)야여골표본적골밀도무현저상관。결론유리대황은곤가이예방당피질격소성골질소송,구유형광적유리대황은곤류원형화합물재대서고골중무현저적축적현상화골파향작용。실험위종골조직원위약효동역학여약대동역학상관련( pD-pK link)각도탐색골파향항골질소송성분작료유익적상시。
Objective To investigate the bone targeted anti-osteoporosis effect of free rhubarb anthraquinone compounds in rats with glucocorticoid-induced osteoporosis.Methods Using fluorescent tracing method, the fluorescence in the epiphysis of the distal femurs was observed in rats with glucocorticoid-induced osteoporosis in situ.It was correlated with bone mineral density (BMD) and bone mineral content (BMC) at the same location.One hundred and twenty-six 4-month-old female SD rats were randomly divided into prednisone group ( Pred) , prednisone +free anthraquinones group ( Pred+FAQ) , and normal control group ( CON) .Each group was further subdivided into 7 subgroups.The administration period was 13 weeks at the last.BMD and BMC in distal part (2 mm) of the femurs were scanned using pQCT.The photofluorogram of the coronary symmetrical section of the bone samples in Pred+FAQ group was obtained using epifluorescence microscope.Results BMD of the distal part of the femur was significantly increased in Pred+FAQ group ( P<0.05) compared to those in Pred group.The fluorescence of the epiphysis of bone samples at all time points elevated or eliminated following the epiphyseal“growth-closed” cycle in Pred+FAQ group.It was not significantly correlated with BMD of the bone samples.BMC was not significantly correlated with BMD of the bone samples. Conclusion Free rhubarb anthraquinone compounds can prevent bone loss due to glucocorticoid-induced osteoporosis.There is no significant accumulation of fluorescence combined free anthraquinone compounds and bone targeting property.This experiment explores a beneficial research model for investigate bone targeted anti-osteoporosis effective components in bone tissue through pharmacodynamics/pharmacokinetics link perspective.